KST Pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
KST Pharma
Largest movements
- Cash -€33,559
down €33,559 (-60.8%), from €55,188 to €21,629
mainly Contributions, distributions and other (-€164,000) and Debts after one year (-€16,271)
- Tangible fixed assets -€31,220
down €31,220 (-21.0%), from €148,638 to €117,419
of which Furniture and vehicles: -€20,937
- Receivables within one year -€9,905
down €9,905 (-27.6%), from €35,850 to €25,945
of which Other amounts receivable: -€9,906
- Profit (loss) carried forward -€163,860
down €163,860 (-99.6%), from €164,512 to €652
- Other debts +€103,569
up €103,569, from €0 to €103,569
- Debts after one year -€16,271
down €16,271 (-100.0%), from €16,271 to €0
- Trade debts +€2,479
up €2,479 (+32.1%), from €7,727 to €10,205
- Other operating charges +€40,987
up €40,987 (+10581.7%), from €387 to €41,374
- Gross operating margin -€18,477
down €18,477 (-13.8%), from €134,211 to €115,734
- Taxes +€3,051
up €3,051 (+11.9%), from €25,665 to €28,716
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €243,680 | €168,506 | -€75,173 | -30.8% |
| Fixed assets | 21/28 | €148,638 | €117,419 | -€31,220 | -21.0% |
| Tangible fixed assets | 22/27 | €148,638 | €117,419 | -€31,220 | -21.0% |
| Furniture and vehicles | 24 | €60,908 | €39,971 | -€20,937 | -34.4% |
| Other tangible fixed assets | 26 | €87,730 | €77,448 | -€10,282 | -11.7% |
| Current assets | 29/58 | €95,041 | €51,088 | -€43,954 | -46.2% |
| Amounts receivable within one year | 40/41 | €35,850 | €25,945 | -€9,905 | -27.6% |
| Trade receivables | 40 | €25,940 | €25,942 | +€2 | 0.0% |
| Other amounts receivable | 41 | €9,910 | €3 | -€9,906 | -100.0% |
| Cash at bank and in hand | 54/58 | €55,188 | €21,629 | -€33,559 | -60.8% |
| Deferred charges and accrued income | 490/1 | €4,003 | €3,514 | -€490 | -12.2% |
| Total equity and liabilities | 10/49 | €243,680 | €168,506 | -€75,173 | -30.8% |
| Equity | 10/15 | €184,972 | €21,112 | -€163,860 | -88.6% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €164,512 | €652 | -€163,860 | -99.6% |
| Amounts payable | 17/49 | €58,708 | €147,395 | +€88,687 | +151.1% |
| Amounts payable after more than one year | 17 | €16,271 | €0 | -€16,271 | -100.0% |
| Financial debts | 170/4 | €16,271 | €0 | -€16,271 | -100.0% |
| Amounts payable within one year | 42/48 | €42,437 | €147,395 | +€104,958 | +247.3% |
| Current portion of amounts payable after more than one year | 42 | €17,750 | €16,271 | -€1,479 | -8.3% |
| Trade debts | 44 | €7,727 | €10,205 | +€2,479 | +32.1% |
| Suppliers | 440/4 | €7,727 | €10,205 | +€2,479 | +32.1% |
| Taxes, remuneration and social security | 45 | €16,960 | €17,349 | +€389 | +2.3% |
| Taxes | 450/3 | €15,495 | €15,770 | +€275 | +1.8% |
| Remuneration and social security | 454/9 | €1,465 | €1,579 | +€114 | +7.8% |
| Other amounts payable | 47/48 | €0 | €103,569 | +€103,569 | |
| Accrued charges and deferred income | 492/3 | €0 | - | = | |
| Remuneration, social security and pensions | 62 | €12,556 | €13,096 | +€540 | +4.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €31,342 | €31,220 | -€122 | -0.4% |
| Other operating charges | 640/8 | €387 | €41,374 | +€40,987 | +10581.7% |
| Gross operating margin | 9900 | €134,211 | €115,734 | -€18,477 | -13.8% |
| Operating profit (loss) | 9901 | €89,925 | €30,043 | -€59,881 | -66.6% |
| Financial income | 75/76B | €0 | €0 | -€0 | -78.7% |
| Recurring financial income | 75 | €0 | €0 | -€0 | -78.7% |
| Financial charges | 65/66B | €1,858 | €1,188 | -€670 | -36.1% |
| Recurring financial charges | 65 | €1,858 | €1,188 | -€670 | -36.1% |
| Profit (loss) for the period before taxes | 9903 | €88,067 | €28,855 | -€59,212 | -67.2% |
| Income taxes | 67/77 | €25,665 | €28,716 | +€3,051 | +11.9% |
| Profit (loss) for the period | 9904 | €62,403 | €140 | -€62,263 | -99.8% |
| Profit (loss) for the period to be appropriated | 9905 | €62,403 | €140 | -€62,263 | -99.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.